Last reviewed · How we verify
Tussionex Pennkinetic — Competitive Intelligence Brief
marketed
Opioid Agonist
Mu-type opioid receptor
Neuroscience
Small molecule
Live · refreshed every 30 min
Target snapshot
Tussionex Pennkinetic (HYDROCODONE) — Teva. Tussionex Pennkinetic works by binding to opioid receptors in the brain, which helps to reduce pain and congestion.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tussionex Pennkinetic TARGET | HYDROCODONE | Teva | marketed | Opioid Agonist | Mu-type opioid receptor | 1943-01-01 |
| Lybalvi | SAMIDORPHAN | Alkermes Inc | marketed | Atypical Antipsychotic [EPC] | Mu-type opioid receptor | 2021-01-01 |
| Olinvyk | OLICERIDINE | Trevena | marketed | Mu-type opioid receptor | 2020-01-01 | |
| Symproic | NALDEMEDINE | Bdsi | marketed | Opioid Antagonist | Mu-type opioid receptor | 2017-01-01 |
| Viberzi | ELUXADOLINE | AbbVie | marketed | mu-Opioid Receptor Agonist [EPC] | Mu-type opioid receptor | 2015-01-01 |
| Movantik | NALOXEGOL | Averitas | marketed | Opioid Antagonist | Mu-type opioid receptor | 2014-01-01 |
| Relistor | METHYLNALTREXONE | Salix Pharms | marketed | Opioid Antagonist | Mu-type opioid receptor | 2008-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
- — Lybalvi · 11351166 · US
- — Lybalvi · 11241425 · US
- — Lybalvi · 9126977 · US
- — Lybalvi · 10300054 · US
- — Lybalvi · 10716785 · US
- — Lybalvi · 11185541 · US
- — Lybalvi · 9517235 · US
- — Lybalvi · 9119848 · US
- — Lybalvi · 8778960 · US
Sponsor landscape (Opioid Agonist class)
- · 4 drugs in this class
- Rising · 2 drugs in this class
- Pfizer · 2 drugs in this class
- Endo · 1 drug in this class
- Fresenius Kabi · 1 drug in this class
- Specgx Llc · 1 drug in this class
- Teva · 1 drug in this class
- Bausch Health · 1 drug in this class
- Collegium Pharm Inc · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tussionex Pennkinetic CI watch — RSS
- Tussionex Pennkinetic CI watch — Atom
- Tussionex Pennkinetic CI watch — JSON
- Tussionex Pennkinetic alone — RSS
- Whole Opioid Agonist class — RSS
Cite this brief
Drug Landscape (2026). Tussionex Pennkinetic — Competitive Intelligence Brief. https://druglandscape.com/ci/hydrocodone. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab